Verzenio Is Significant– Cuts The Risk of Cancer Coming Back In Some Women With Early Breast Cancer– A First For CDK4/6 Inhibitors

Updated June 29th, 2020

Verzenio Is Significant– Cuts The Risk of Cancer Coming Back In Some Women With Early Breast Cancer– A First For CDK4/6 Inhibitors

During a clinical trial, researchers found that CDK4/CDK6 inhibitor Verzenio may have a huge impact on women battling early stage breast cancer by decreasing the likelihood of the cancer returning.

NOW
PLAYING
Irish Singer Linda Nolan Battling Breast Cancer Alongside Her Sister
NOW
PLAYING
Ovarian Cancer Support Organizations
NOW
PLAYING
New Study Shows that People Battling Breast Cancer Who Drink Sugar-Sweetened Soda May Be Putting Their Health at Risk
NOW
PLAYING
Study Finds Minority Communities Not Receiving Adequate Genetic Testing For Breast & Ovarian Cancer; This Can Be a Life-Saving Resource
NOW
PLAYING
Many Women Say They're Drinking More During Pandemic, 70% Don't Know Alcohol Increases Cancer Risk, According to SurvivorNet Survey
NOW
PLAYING
"A Second Opportunity at Life"-- Maribel Ramos Is Thriving 5 Years After Experimental Immunotherapy for Triple-Negative Breast Cancer

Treatment: Lymphedema

SEE MORE   

Treatment: Lymphedema

Lymphedema is a chronic swelling that can occur after breast cancer surgery and radiation.

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.